Morbid obesity: A significant risk factor for failure of two-stage revision total hip arthroplasty for infection

Journal of Bone and Joint Surgery - American Volume

Volumn 97, Issue 4, 2015, Pages 326-332

  Houdek, Matthew T ^a   Wagner, Eric R ^a   Watts, Chad D ^a   Osmon, Douglas R ^b   Hanssen, Arlen D ^a   Lewallen, David G ^a   Mabry, Tad M ^a  

^a Department of Orthopedic Surgery ^*  (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HARRIS HIP SCORE; HIP ARTHROPLASTY; HUMAN; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MORBID OBESITY; PERIPROSTHETIC FRACTURE; PERIPROSTHETIC JOINT INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTHESIS DISLOCATION; PROSTHESIS FAILURE; PROSTHESIS LOOSENING; REINFECTION; REOPERATION; SURGICAL RISK; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; TWO STAGE REVISION TOTAL HIP ARTHROPLASTY; ADVERSE EFFECTS; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; DEBRIDEMENT; DIABETES MELLITUS; INCIDENCE; KAPLAN MEIER METHOD; MICROBIOLOGY; OBESITY, MORBID; PROGNOSIS; PROSTHESIS-RELATED INFECTIONS; RECURRENT DISEASE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT FAILURE;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DEBRIDEMENT; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OBESITY, MORBID; PROGNOSIS; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; RECURRENCE; REOPERATION; RISK FACTORS; TREATMENT FAILURE;

EID: 84928052041     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.N.00515     Document Type: Article

References (37)

1. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011 Feb 12;377(9765):557-67. Epub 2011 Feb 3.
2. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012 Feb 1;307(5):491-7. Epub 2012 Jan 17.
3. Nho SJ, Kymes SM, Callaghan JJ, Felson DT. The burden of hip osteoarthritis in the United States: epidemiologic and economic considerations. J Am Acad Orthop Surg. 2013;21(Suppl 1):S1-6.
4. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5.
5. Changulani M, Kalairajah Y, Peel T, Field RE. The relationship between obesity and the age at which hip and knee replacement is undertaken. J Bone Joint Surg Br. 2008 Mar;90(3):360-3.
6. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009 Jan;91(1):128-33.
7. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008 Oct;23(7):984-91. Epub 2008 Apr 10.
8. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty. 2009 Sep; 24(6)(Suppl):105-9. Epub 2009 Jun 2.
9. Jämsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am. 2012 Jul 18;94(14):e101.
10. Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am. 2012 May 2;94(9):794-800.
11. Bozic KJ, Ward DT, Lau EC, Chan V, Wetters NG, Naziri Q, Odum S, Fehring TK, Mont MA, Gioe TJ, Della Valle CJ. Risk factors for periprosthetic joint infection following primary total hip arthroplasty: a case control study. J Arthroplasty. 2014 Jan;29(1):154-6. Epub 2013 May 20.
12. Haverkamp D, Klinkenbijl MN, Somford MP, Albers GH, van der Vis HM. Obesity in total hip arthroplasty - does it really matter? A meta-analysis. Acta Orthop. 2011 Aug;82(4):417-22. Epub 2011 Jun 10.
13. Friedman RJ, Hess S, Berkowitz SD, Homering M. Complication rates after hip or knee arthroplasty in morbidly obese patients. Clin Orthop Relat Res. 2013 Oct; 471(10):3358-66. Epub 2013 May 14.
14. Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty. 2009 Sep;24(6)(Suppl):84-8. Epub 2009 Jul 15.
15. Hanssen AD, Spangehl MJ. Treatment of the infected hip replacement. Clin Orthop Relat Res. 2004 Mar;420:63-71.
16. Sanchez-Sotelo J, Berry DJ, Hanssen AD, Cabanela ME. Midterm to long-term followup of staged reimplantation for infected hip arthroplasty. Clin Orthop Relat Res. 2009 Jan;467(1):219-24. Epub 2008 Sep 24.
17. Haddad FS, Muirhead-Allwood SK, Manktelow AR, Bacarese-Hamilton I. Two-stage uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br. 2000 Jul;82(5):689-94.
18. McGrory BJ, Morrey BF, Rand JA, Ilstrup DM. Correlation of patient questionnaire responses and physician history in grading clinical outcome following hip and knee arthroplasty. A prospective study of 201 joint arthroplasties. J Arthroplasty. 1996 Jan;11(1):47-57.
19. Workgroup Convened by the Musculoskeletal Infection Society. New definition for periprosthetic joint infection. J Arthroplasty. 2011 Dec;26(8):1136-8.
20. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969 Jun;51(4):737-55.
21. Maradit Kremers H, Visscher SL, Kremers WK, Naessens JM, Lewallen DG. Obesity increases length of stay and direct medical costs in total hip arthroplasty. Clin Orthop Relat Res. 2014 Apr;472(4):1232-9. Epub 2013 Oct 8.
22. Elson LC, Barr CJ, Chandran SE, Hansen VJ, Malchau H, Kwon YM. Are morbidly obese patients undergoing total hip arthroplasty at an increased risk for component malpositioning? J Arthroplasty. 2013 Sep;28(8)(Suppl):41-4. Epub 2013 Jul 30.
23. Schwarzkopf R, Thompson SL, Adwar SJ, Liublinska V, Slover JD. Postoperative complication rates in the "super-obese" hip and knee arthroplasty population. J Arthroplasty. 2012 Mar;27(3):397-401. Epub 2011 Jun 14.
24. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008 Jul;466(7):1710-5. Epub 2008 Apr 18.
25. Namba RS, Paxton L, Fithian DC, Stone ML. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty. 2005 Oct;20(7)(Suppl 3):46-50.
26. Dowsey MM, Choong PF. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res. 2008 Jan;466(1):153-8. Epub 2008 Jan 3.
27. Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007 Jan;89(1):33-8.
28. Chee YH, Teoh KH, Sabnis BM, Ballantyne JA, Brenkel IJ. Total hip replacement in morbidly obese patients with osteoarthritis: results of a prospectively matched study. J Bone Joint Surg Br. 2010 Aug;92(8):1066-71.
29. Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect. 1999;48:111-22.
30. Kraay MJ, Goldberg VM, Fitzgerald SJ, Salata MJ. Cementless two-staged total hip arthroplasty for deep periprosthetic infection. Clin Orthop Relat Res. 2005 Dec;441:243-9.
31. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 2004 Sep 21;110(12):1564-71. Epub 2004 Sep 13.
32. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012 May;71(2):298-306. Epub 2012 Mar 14.
33. Fontana L, Eagon JC, Colonna M, Klein S. Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss. Rejuvenation Res. 2007 Mar;10(1):41-6.
34. Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am. 2003 Jan;85(1):27-32.
35. Saleh KJ, Celebrezze M, Kassim R, Dykes DC, Gioe TJ, Callaghan JJ, Salvati EA. Functional outcome after revision hip arthroplasty: a metaanalysis. Clin Orthop Relat Res. 2003 Nov;416:254-64.
36. Lübbeke A, Katz JN, Perneger TV, Hoffmeyer P. Primary and revision hip arthroplasty: 5-year outcomes and influence of age and comorbidity. J Rheumatol. 2007 Feb;34(2):394-400. Epub 2006 Nov 15.
37. Adelani MA, Crook K, Barrack RL, Maloney WJ, Clohisy JC. What is the prognosis of revision total hip arthroplasty in patients 55 years and younger? Clin Orthop Relat Res. 2014 May;472(5):1518-25. Epub 2013 Nov 19.